“In 3 years, this will be the biggest pharmaceutical valley of the Yangtze River Delta Region”, says the responsible person of Management Committee of Jiangsu Life Science Innovation Park. “It is because of the support from a batch of innovative pharmaceutical enterprises such as Sanhome International New Pharmaceutical Development Center, we have been so confident.”

“Absolutely, a initial scale of the bio-pharmaceutical industry that will worth 50 billion RMB in 3 years is taking place”, expressed by related responsible person of Trade and Economy Committee. Along with the development of Jiangsu Life Science Innovation Park and Nanjing Bio-pharmaceutical Research Institute, Nanjing will take a lead in the global bio-economy field. In the future 3 years, the country, province, municipality and district will jointly invest 10 billion funds and directly bring along all sorts of social investment worth 100 billion more. Development of a batch of bio-pharmaceutical enterprises with strong innovation and self-owned intellectual properties will be supported and by the time of 2012, total production value of the industry will go beyond 50 billion RMB.

July, 2009, Nanjing University Nanjing Bio-pharmaceutical Research Institute, jointly founded by Nanjing New & High Technology Development Zone and Nanjing University was founded. It means that a world-class development platform has been established in the Jiangbei bio-pharmaceutical research and development center.

At the same time, Jiangsu Kanion Hongdao Modern Chinese Traditional Medicine Industrialized Production Base is kicked off in Nanjing Pukou Bio-pharmaceutical Industrial Base of State Torch Program – Third Bridge Park of Pukou Economic Development Zone. In the end of 2009, Sanhome Pharmaceutical signed the investment agreement for Jiangsu Life Science Innovation Park by investing 200 million RMB to build the program of Sanhome International New Pharmaceutical Development Center, which will specialize in developing new pharmaceutical. (Nanjing Daily)